Hello everyone! I am Rajita Majumdar with USAID MTaPS program: www.mtapsprogram.org

Hello, This is Zubayer Hussain from USAID MTaPS.

Michel Pacqué, JSI RESEARCH & TRAINING INSTITUTE, INC. --   Child Health Lead MOMENTUM Integrated Health Resilience

Hello, Bistra Zheleva, Children's HeartLink

Hello Kate Kikule, Principal Technical Advisor - Pharmaceutical Regulatory Systems MTaPS

Hello everyone. Maimunat Alex-Adeomi. American Academy of Pediatrics

Good day! Manjari Quintanar, Medical Devices and Health Technologies at PATH

Hello colleagues. I am Patrick Gaparayi, UNICEF Supply Division, Copenhagen

Thank you all for coming! Feel free to add your questions in the chat.

I was surprised not to see Malawi in having a registration mechanism for medical devices - I hope I have not missed it

Sorry - Malawi was not studied in this exercise- there were only 9 countries

Thanks @Jane and @Kate...

@Fatima - The 9 countries studied were: Nepal, Bangladesh, Mali, Senegal, Rwanda, Tanzania, Uganda and the DRC

Thank you @Smita,

and Mozambique

Questions to Jane: (1) During your survey, is there any possible correlation between the number of registered products and the number of importers/manufacturers/market authorization holders? (2) Is there any evidence that adequate product registration in a given country would impact positively on its availability at the service delivery points? (3) What could be your interpretation on a product like Ceftriaxone that has more than 200 market authorization holders in Bangladesh (maybe it is a red flag)?

honestly am so surprise to see that NEPAL is not having 4% chlorhexidine gel in their list of medical registration. In 2012 a team of health professionals visited Nepal for experience sharing on the use of 4% chlorhexidine gel application in their country. A success story. What happened planned now?

What happened now?

CHX is registered in Nepal- it is one of the few registered products - it was shown in blue on the table as having 1-2 products registered

Here is the link to the technical document of this mapping

https://www.mtapsprogram.org/our-resources/improving-access-to-maternal-newborn-and-child-health-medical-products-in-low-and-middle-income-countries-considerations-for-effective-registration-systems/

The information on registration fees is interesting but only one cost to the supplier to register products. Do you have any information on the LOE and costs to prepare, submit etc dossiers per county? Thank you

thanks for your interest in this webinar - we will share the recording and the presentations and you already have the link to the report

Feel free to reach out to us with any specific questions you may have

very interesting results and unfortunately lots of work to be done. Question: in a recent assessment of cardiovascular services in Africa, this problem for lack of specialized supplies and medicines emerged for many countries. Those tend to be the opposite - high cost and low volume but companies also were not interested in even entering the markets because of perceived lack of market opportunities. Any suggestions on how to approach that challenge?

Did you find differences in imported versus locally produced commodities in the registration process? Do you know of countries which government promotes/incentives local production?

thank you for this great webinar